全文获取类型
收费全文 | 685篇 |
免费 | 69篇 |
专业分类
754篇 |
出版年
2022年 | 12篇 |
2020年 | 9篇 |
2019年 | 5篇 |
2018年 | 5篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 9篇 |
2014年 | 19篇 |
2013年 | 18篇 |
2012年 | 33篇 |
2011年 | 32篇 |
2010年 | 21篇 |
2009年 | 25篇 |
2008年 | 33篇 |
2007年 | 29篇 |
2006年 | 27篇 |
2005年 | 38篇 |
2004年 | 35篇 |
2003年 | 27篇 |
2002年 | 18篇 |
2001年 | 21篇 |
2000年 | 32篇 |
1999年 | 21篇 |
1998年 | 17篇 |
1997年 | 17篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1994年 | 8篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 10篇 |
1989年 | 11篇 |
1988年 | 11篇 |
1987年 | 9篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 10篇 |
1983年 | 7篇 |
1981年 | 5篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1975年 | 8篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 5篇 |
1971年 | 6篇 |
1969年 | 6篇 |
1968年 | 4篇 |
1967年 | 5篇 |
排序方式: 共有754条查询结果,搜索用时 0 毫秒
1.
D A Roe 《Life sciences》1974,15(7):1219-1234
Drugs can increase nutrient requirements through various mechanisms and if these requirements are not met by dietary modification or provision of nutrient supplements, deficiency disease will result. Commoner nutritional effects of drugs consist in the insidious development of hypovitaminoses; other serious nutritional consequences of drug intake include growth impairment and, in the case of vitamin antagonists, poisoning through interference with metabolic processes dependent on the activity of vitamins or coenzymes. Interactions may exist between pharmacologic agents and nutrients with respect to their absorption, transport, metabolism and excretion. Single drugs can cause nutrient depletion by more than one mechanism and multiple drug regimens can deplete nutrient stores by a synergistic effect. Risks of drug-induced malnutrition with drugs increase with dose and duration of intake, marginal diets and co-existence of disease which increases requirements for the same nutrients that are affected by the drug. 相似文献
2.
3.
Coleman Gross Christine M. Blasey Robert L. Roe Joseph K. Belanoff 《Obesity (Silver Spring, Md.)》2010,18(12):2295-2300
Antipsychotic medications are associated with significant weight gain, type 2 diabetes mellitus, dyslipidemia, and increased cardiovascular risk. The objective of this study was to determine whether mifepristone, a glucocorticoid receptor antagonist, could prevent risperidone‐induced weight gain. Using a 2:2:1 randomization scheme, 76 lean, healthy men (BMI 18–23 kg/m2) age 18–40 years were randomized to risperidone (n = 30), risperidone plus mifepristone (n = 30) or mifepristone (n = 16) daily for 28 days in an institutional setting. Subjects were provided food ad libitum. Body weight was measured daily. Metabolic measures were taken at study onset, midpoint, and end. Analyses of covariance indicated that the group receiving risperidone plus placebo gained significantly more weight (P < 0.001) and exhibited a significantly greater increase in waist circumference (P < 0.05) than the group receiving risperidone plus mifepristone. Significant differences were also observed for metabolic measures including fasting insulin (P < 0.001) and triglyceride levels (P < 0.05). Mifepristone attenuated increases in weight and reduced the metabolic changes induced by risperidone use, replicating results from a prior study of olanzapine‐induced weight gain. These findings suggest mechanistic involvement of the hypothalamic‐pituitary‐adrenal axis in the weight and cardiometabolic side effects of antipsychotic medications. Future research should continue to test the potential of glucocorticoid antagonists to alleviate the deleterious side effects associated with use of antipsychotic medications. 相似文献
4.
5.
6.
7.
The sequence of tRNAGCCGly from human placenta was determined by recently developed postlabeling techniques. The tRNA was digested completely with RNases T1 and A in the presence of alkaline phosphatase, the oligonucleotides were 3'-terminally (3H)-labeled, mapped on PEI-cellulose thin layers, isolated, and sequenced by methods based on base-specific cleavages. Overlaps were obtained by readout sequencing techniques on polyacrylamide gels and PEI-cellulose thin layers. The thin-layer readout technique was used also to locate and identify modified nucleotides. The primary structure was found to exhibit a large degree of homology (94.6%) with silkworm tRNAGCCGly but only 67.6% homology with human tRNACCCGly. 相似文献
8.
9.
10.
J. Gibert D. Campillo V. Eisenmann E. García-Olivares A. Malgosa D. A. Roe M. J. Walker C. Borja F. Sánchez F. Ribot Ll. Gibert S. Albadalejo A. Iglesias C. Ferrández E. Maestro 《Human Evolution》1999,14(1-2):29-46
In SE Spain, recent excavations in the Orce basin and at Cueva Victoria indicate presence of both hominids and hominid activity
from the Plio-Pleistocene boundary and early Lower Pleistocene. 相似文献